Researchers assessed the accuracy of 18 FDA-approved blood glucose monitoring systems, representing approximately 90% of those available in the U.S. from 2013 to 2015.
The guideline, developed by the Joint British Diabetes Societies for Inpatient Care, noted that many patients taking insulin will know more about their usual regimen than the medical and nursing staff responsible for their care.
Basal insulin analogs and NPH insulin had similar rates of hypoglycemia hospital visits, glycemic control in type 2 diabetes
Researchers used data from Kaiser Permanente of Northern California to retrospectively assess patients with type 2 diabetes who initiated a long-acting insulin analog or NPH insulin between Jan. 1, 2006, and Sept. 30, 2015.
In a prospective cohort analysis of patients in the Atherosclerosis Risk in Communities study without diagnosed diabetes at baseline, both fasting glucose and HbA1c level were measured in a single blood sample taken during a visit in 1990 to 1992.
The module offers resources for clinicians to help identify key practice-level interventions to optimize the delivery of care, motivate patients to improve their self-management skills, and help practices deliver optimal diabetes care.
The findings may help inform decisions about insulin therapy for patients with type 2 diabetes, for example, when minimizing weight gain or nocturnal hypoglycemia is a priority.
Inpatients with type 2 diabetes who received automated closed-loop delivery of insulin spent more time in the target blood glucose range than those who received insulin subcutaneously, with no difference in rates of hypoglycemia.
The sensor is coated with a fluorescent chemical that produces a small amount of light when exposed to blood glucose. Every five minutes, it sends glucose measurements to a compatible device that is running a device-specific mobile app.